FIELD: biotechnology, molecular biology. SUBSTANCE: invention can be used for the development of functionally active tyrosine-specific protein kinase chimeras. The constructed chimeric receptor comprises b-noncellular moiety that recognize specifically cell-target or infectious agent-target, transmembrane domain and intracellular moiety representing human or swine protein-tyrosine kinase Syk, or protein-tyrosine kinase ZAP-70, or derivative of CD28. DNA encoding chimeric receptor is cloned into expressive cowpox virus vector that is used for transfection of mammalian cells. Transfected cells expressing two or three different chimeric receptors comprising, respectively, intracellular moiety of protein-tyrosne kinase Syk and CD28 or intracellular moiety of ZAP-70, Sre and CD28 are administrated to mammal in effective dose for destroying cell-target or infectious agent-target. Invention provides the development of agents that are able to target therapeutic cells for specific recognition and destroying cell-target or infectious agent-target. EFFECT: improved destroying method, valuable biological properties. 32 cl, 19 dwg
Title |
Year |
Author |
Number |
PROTEIN CHIMERIC RECEPTOR, DNA ENCODING PROTEIN CHIMERIC RECEPTOR |
1994 |
- Brajan Sid
- Charl'Z Romeo
- Val'Demar Kolanus
|
RU2158305C2 |
REDIRECTION OF CELLULAR IMMUNITY BY CHIMERIC RECEPTORS |
1996 |
- Brajen Sid
- Charl'Z Romeo
- Val'Demar Kolanus
|
RU2167676C2 |
METHOD OF DIRECTION OF IMMUNE RESPONSE INDUCTION, DNA, VECTOR, METHOD OF TREATMENT |
1992 |
- Brajan Sid
- Charl'Z Romeo
- Val'Demar Kolanus
|
RU2161044C2 |
CELL |
2016 |
- Pyule Marten
- Kordoba Shon
- Tomas Sajmon
- Kong Kkhaj
|
RU2729158C2 |
IMMUNE CELLS EXPRESSING INVERSE UNIVERSAL CHIMERIC ANTIGEN RECEPTOR, FOR TARGETING VARIOUS MULTIPLE ANTIGENS AND METHOD FOR PRODUCTION AND USE THEREOF FOR TREATING CANCER, INFECTIONS AND AUTOIMMUNE DISEASES |
2019 |
|
RU2824391C2 |
CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATION DOMAINS |
2018 |
|
RU2800922C2 |
CONDITIONALLY ACTIVE CHIMERIC ANTIGENIC RECEPTORS FOR MODIFIED T CELLS |
2016 |
|
RU2759957C2 |
CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS |
2015 |
|
RU2764074C2 |
CHIMERIC ANTIGEN RECEPTOR WITH COSTIMULATORY DOMAIN 4-1BB |
2020 |
- Kwon, Byoung S.
- Kim, Kwanghee
- Chung, Jiwon
- Chang, Young Gyoon
- Yi, Bo-Rim
- Lee, Jungyun
- Lee, Sae Rom
- Son, Hyuntae
- Lee, Hye Mi
- Yoo, Eun Hye
|
RU2830540C2 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTITUMOUR EFFECT, AND METHOD FOR REDUCING PD-L1 INHIBITING EFFECT ON HUMAN T-CELLS |
2016 |
|
RU2688692C2 |